Guidelines for Biomedical HIV Prevention Trials
The good participatory practice (GPP) guidelines were created in 2007 to set global standards in stakeholder engagement for biomedical HIV prevention trials. The guidelines were reviewed in 2010 following extensive consultation. This revised version of the GPP guidelines is circulated in draft form for comments to be sent by 31 October 2010 to firstname.lastname@example.org or email@example.com. The GPP guidelines are intended to provide trial funders, sponsors, and implementers with systematic guidance on how to effectively engage with all stakeholders in the design and conduct of biomedical HIV prevention trials.